glp 1 and bipolar disorder Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? An analysis on the role
Description
At OC&C Strategy Consultants, we are partnering with clients to navigate this transformation with rigor and foresight
Some people find that splitting their dose helps maintain more consistent appetite suppression throughout the week
Here, we sought to test these hypotheses by recruiting a cohort with obesity 19 either taking GLP-1 RAs or not and test breath alcohol content (BrAc) and subjective feelings after an alcohol challenge dose
M2, muscarinic acetylcholine receptor subtype 2
